Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
02/2015
02/19/2015WO2015021561A1 Compositions and methods for making noscapine and synthesis intermediates thereof
02/19/2015US20150051403 Use of 15-benzylidene-14-deoxy-11, 12-dehydroandrographolide derivative in manufacture of medicaments for protecting liver and anti-hepatitis C virus
02/19/2015US20150051395 Sulfonamide derivative and medicinal use thereof
02/19/2015US20150051261 Methods of Treating Fatty Liver Disease
02/19/2015US20150051247 Compounds and methods for treating cancer by inhibiting the urokinase receptor
02/19/2015US20150051238 Pyrazole aminopyrimidine derivatives as lrrk2 modulators
02/19/2015US20150051225 Substituted imidazoles as n-type calcium channel blockers
02/19/2015US20150051222 Process for the preparation of n-[5-(3,5-difluoro-benzyl)-1h-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide
02/19/2015US20150051208 Pyridinones
02/19/2015US20150051203 Triazole derivatives as hsp90 inhibitors
02/19/2015US20150051196 Inhibitors of c-fms kinase
02/19/2015US20150051195 Novel viral replication inhibitors
02/19/2015US20150051187 Compounds useful as inhibitors of atr kinase
02/19/2015US20150051163 Combination therapy for treating cancer
02/18/2015EP2837623A1 Novel 1-substituted indazole derivative
02/18/2015EP2836490A2 Indole and indazole compounds that activate ampk
02/18/2015EP2836486A1 Diaminopyrimidines useful as inhibitors of the human respiratory syncytial virus (rsv)
02/17/2015US8958165 Cyanine compound and optical filter and optical recording material containing same
02/17/2015US8957222 Process for preparing intermediates of peripherally-selective inhibitors of dopamine-β-hydroxylase involving catalytic asymmetric hydrogenation
02/17/2015US8957105 Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
02/17/2015US8957085 Carboxamide bioisosteres of opiates
02/17/2015US8957081 Compounds and compositions as protein kinase inhibitors
02/17/2015US8957075 O-GlcNAc transferase inhibitors and uses thereof
02/17/2015US8957074 Pyrrolopyrimidine compounds as inhibitors of CDK4/6
02/17/2015US8957073 Unsaturated nitrogen heterocyclic compounds useful as PDE10 inhibitors
02/17/2015US8957069 Benzofuran derivatives
02/17/2015US8957063 Amine and ether compounds which modulate the CB2 receptor
02/17/2015US8957062 Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment
02/17/2015CA2759163C Method for producing olmesartan medoxomil
02/17/2015CA2726579C Novel uracil compound or salt thereof having human deoxyuridine triphosphatase inhibitory activity
02/17/2015CA2679971C Glucokinase activator
02/17/2015CA2657745C Pyrimidine derivatives and their use as pesticides
02/17/2015CA2647423C Triazolone derivative
02/17/2015CA2635842C Prokineticin 1 receptor antagonists
02/12/2015WO2015020184A1 Aromatic compound
02/12/2015WO2015019365A1 N-cyanomethylamides as inhibitors of janus kinase
02/12/2015WO2015019325A1 Benzimidazolyl-methyl urea derivatives as alx receptor agonists
02/12/2015WO2015018754A1 Novel pyrazine amide compounds
02/12/2015WO2015018356A1 Diarylhydantoin derivative, and preparation method, pharmaceutical composition, and application thereof
02/12/2015US20150045562 Chemical Process for Preparing Spiroindolones and Intermediates Thereof
02/12/2015US20150045404 Schweinfurthin analogues
02/12/2015US20150045399 Liver X Receptor (LXR) Modulators For The Treatment Of Dermal Diseases, Disorders And Conditions
02/12/2015US20150045395 Method of using an indolinone molecule and derivatives for inhibiting liver fibrosis and hepatitis
02/12/2015US20150045393 Novel Cysteine Protease Inhibitors and Uses Thereof
02/12/2015US20150045384 Morphan and Morphinan Analogues, and Methods of Use
02/12/2015US20150045378 Aromatic ring compound
02/12/2015US20150045367 Cinnamic acid hydroxyamides as inhibitors of histone deacetylase 8
02/12/2015US20150045364 Pyridine and Pyrazine derivative for the Treatment of CF
02/12/2015US20150045357 Small molecule inhibitors of mcl-1 and uses thereof
02/12/2015US20150045355 Fused tricyclic compounds as raf kinase inhibitors
02/12/2015US20150045339 Nitrogen-containing heterocyclic compound or salt thereof
02/12/2015US20150045326 Novel pyrazine amide compounds
02/12/2015US20150045282 Compositions containing delta-9-thc-amino acid esters and process of preparation
02/11/2015EP2834234A1 Fused cyclopentyl antagonists of ccr2
02/11/2015EP2834233A1 New alpha2 adrenoceptor agonists
02/11/2015EP2834232A1 3,5-diaminopyrazole kinase inhibitors
02/11/2015EP2834230A1 Carboxamide compounds and their use as calpain inhibitors v
02/11/2015CN104350050A 5-卤代吡唑苯并呋喃基甲酰胺类化合物 5-halo-pyrazol-benzofuranyl carboxamides
02/11/2015CN104350049A 作为激酶抑制剂的取代氨基喹唑啉 As kinase inhibitors substituted aminoquinazolinone
02/11/2015CN104350042A 脑啡肽酶抑制剂 Neprilysin inhibitor
02/11/2015CN104350040A 芳环化合物 Aromatic compounds
02/11/2015CN104349675A 植物生长调节化合物 Plant growth regulating compounds
02/11/2015CN104342126A 有机电致发光材料和有机电致发光器件 Organic electroluminescent materials and organic electroluminescent devices
02/11/2015CN104342124A 一种基于苯并咪唑的磷光发光主体材料 Based on the phosphorescent host material benzimidazole
02/11/2015CN104341403A 一种2,5-二杂环取代萘基噁烷衍生物及其制备方法 One kind of heterocyclic substituted naphthalene 2,5-dioxane derivatives group and its preparation method
02/11/2015CN104341402A 一种制备替卡格雷中间体的方法 An intermediate prepared ticagrelor
02/11/2015CN104341401A C型肝炎病毒复制的新型抑制剂 Novel inhibitors of hepatitis C virus replication
02/11/2015CN104341396A 二芳基乙内酰脲衍生物、其制备方法、药物组合物和应用 Diaryl-hydantoin derivatives, their preparation, pharmaceutical compositions and applications
02/11/2015CN104341395A 新的吡咯化合物、它们的制备方法和含有它们的药物组合物 The new pyrrole compounds, their preparation and pharmaceutical compositions containing them
02/11/2015CN104341383A 新型2′-胺甲酰基联苯类化合物及其在抗肝纤维化中的应用 2'-carbamoyl novel biphenyl compounds and their application in anti-liver fibrosis
02/11/2015CN103402996B 可用于治疗年龄相关性黄斑变性(amd)的吲哚化合物或其类似物 For the treatment of age-related macular degeneration (amd) indole compound or an analogue thereof
02/11/2015CN102656165B 糖苷衍生物及其用途 Glycoside derivatives and their use
02/11/2015CN102174024B 2,4-嘧啶二胺化合物及其用途 2,4-pyrimidinediamine compounds and use thereof
02/10/2015US8952192 Phosphorylated and branched dihydroxy-pentane-dione (DPD) analogs as quorum sensing inhibitors in bacteria
02/10/2015US8952180 Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors
02/10/2015US8952169 N-substituted benzamides and methods of use thereof
02/10/2015US8952167 Pseudorotaxanes, rotaxanes and catenanes formed by metal ions templating
02/10/2015US8952157 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
02/10/2015US8952154 Process for the preparation of lapatinib and its ditosylate salt
02/10/2015US8952151 Histone demethylase inhibitors
02/10/2015US8952140 Compound amycolose derivative, method for producing the same, and use of the same
02/10/2015US8952053 Prodrugs of substituted 1,3-dioxanes and their uses
02/10/2015US8952050 Modulators of ATP-binding cassette transporters
02/10/2015US8952049 Modulators of ATP-binding cassette transporters
02/10/2015US8952037 Heteroaryloxycarbocyclyl compounds as PDE10 inhibitors
02/10/2015US8952026 PRMT1 inhibitors and uses thereof
02/10/2015US8952024 Herbicidal pyrimidone derivatives
02/10/2015US8952004 CXCR3 receptor antagonists
02/10/2015CA2672956C Calcium receptor modulating agents
02/10/2015CA2632437C 1,2,4-triazol-1-yl bisphenyl derivatives for use in the treatment of endocrine-dependent tumours
02/05/2015WO2015017589A1 1,4-disubstituted pyridazine derivatives and their use for treating smn-deficiency-related conditions
02/05/2015WO2015016728A1 Urea compounds and their use as faah enzyme inhibitors
02/05/2015WO2015016335A1 Tetrazolinone compound and use thereof
02/05/2015WO2015016206A1 Heterocyclic compound
02/05/2015WO2015016195A1 Wnt SIGNALING INHIBITOR
02/05/2015WO2015014465A1 Novel sterically hindered cyclic amines
02/05/2015WO2015014230A1 Matrix metalloproteinase inhibitor and use thereof
02/05/2015WO2015013835A1 Piperazine derivatives as hiv protease inhibitors
02/05/2015US20150038716 Methods for the preparation of hiv attachment inhibitor piperazine prodrug compound
02/05/2015US20150038707 Process for making cgrp receptor antagonists
1 2 3 4 5 6 7 8 9 10 11 12 ... 694